Jiangsu, China

Ajuan Dai

This inventor holds 1 USPTO granted patent. Top assignees: Wuxi Hongrui Bio-Pharma-Tech Co., Ltd., Other. Active years: 2014.


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:

goldMedal1 out of 1 
 
Wuxi Hongrui Bio-Pharma-Tech Co., Ltd.
 patent
silverMedal1 out of 834,350 
Other
 patents
where one patent can have more than one assignee

Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ajuan Dai: Innovator in Non-Steroidal Anti-Inflammatory Medicaments

Introduction

Ajuan Dai is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of non-steroidal anti-inflammatory medicaments. His innovative work focuses on improving the efficacy and safety of these medications.

Latest Patents

Ajuan Dai holds a patent for "Aryl (ethanoic) propanoic acid ascorbyl ester, preparation method thereof and medicament containing the same." This invention involves the design and synthesis of ascorbyl ester derivatives of aryl (ethanoic) propanoic acid, which are used in common antipyretic analgesic medicaments like ibuprofen, ketoprofen, and naproxen. The invention demonstrates remarkable antipyretic and analgesic effects, making it suitable for various age groups, including the elderly, infants, and children. The ascorbyl ester derivatives enhance water solubility, facilitate intravenous administration, and improve bioavailability while reducing gastrointestinal stimulation.

Career Highlights

Ajuan Dai has worked with Wuxi Hongrui Bio-Pharma-Tech Co., Ltd., where he has contributed to the advancement of pharmaceutical technologies. His work has focused on creating innovative solutions for pain relief and inflammation treatment.

Collaborations

Ajuan has collaborated with notable professionals in his field, including Xinning Liu and Yang Sun. These collaborations have further enriched his research and development efforts.

Conclusion

Ajuan Dai's contributions to the field of non-steroidal anti-inflammatory medicaments highlight his innovative spirit and dedication to improving healthcare. His work continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…